We are live on ! Find out more
IART icon

Integra LifeSciences

259 hedge funds and large institutions have $3.96B invested in Integra LifeSciences in 2019 Q1 according to their latest regulatory filings, with 47 funds opening new positions, 100 increasing their positions, 80 reducing their positions, and 36 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more funds holding in top 10

Funds holding in top 10: 12 (+1)

31% more first-time investments, than exits

New positions opened: 47 | Existing positions closed: 36

25% more repeat investments, than reductions

Existing positions increased: 100 | Existing positions reduced: 80

23% more capital invested

Capital invested by funds: $3.23B → $3.96B (+$731M)

4% more funds holding

Funds holding: 248259 (+11)

0.56% less ownership

Funds ownership: 83.99%83.43% (-0.56%)

58% less call options, than puts

Call options by funds: $7.84M | Put options by funds: $18.5M

Holders
259
Holders Change
+11
Holders Change %
+4.44%
% of All Funds
5.61%
Holding in Top 10
2
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+100%
% of All Funds
0.04%
New
47
Increased
100
Reduced
80
Closed
36
Calls
$7.84M
Puts
$18.5M
Net Calls
-$10.6M
Net Calls Change
-$11.6M
Name Holding Trade Value Shares
Change
Change in
Stake
Capital Research Global Investors
1
Capital Research Global Investors
California
$501M -$33.3M -653,508 -7%
BlackRock
2
BlackRock
New York
$373M -$2.17M -42,606 -0.6%
Vanguard Group
3
Vanguard Group
Pennsylvania
$351M +$4.75M +93,205 +2%
CIP
4
Champlain Investment Partners
Vermont
$305M +$3.96M +77,845 +1%
Fidelity Investments
5
Fidelity Investments
Massachusetts
$269M -$77.3M -1,517,497 -24%
Wellington Management Group
6
Wellington Management Group
Massachusetts
$248M +$7.62M +149,640 +3%
Janus Henderson Group
7
Janus Henderson Group
United Kingdom
$160M +$35.1M +688,761 +32%
ClearBridge Investments
8
ClearBridge Investments
New York
$136M +$21.7M +426,578 +21%
Capital International Investors
9
Capital International Investors
California
$126M +$7.32M +143,823 +7%
State Street
10
State Street
Massachusetts
$115M +$3.21M +63,108 +3%
Brown Advisory
11
Brown Advisory
Maryland
$72.4M +$14.6M +287,435 +28%
Invesco
12
Invesco
Georgia
$67.2M -$135K -2,650 -0.2%
Capital World Investors
13
Capital World Investors
California
$63.4M
VNIM
14
Vaughan Nelson Investment Management
Texas
$61.9M +$11.7M +230,010 +26%
Jennison Associates
15
Jennison Associates
New York
$44.1M -$3.48M -68,333 -8%
Dimensional Fund Advisors
16
Dimensional Fund Advisors
Texas
$43.8M +$3.14M +61,604 +9%
Fisher Asset Management
17
Fisher Asset Management
Washington
$43.2M -$8.67M -170,151 -18%
Geode Capital Management
18
Geode Capital Management
Massachusetts
$42.9M +$1.97M +38,701 +5%
ACH
19
ArrowMark Colorado Holdings
Colorado
$41.2M +$3.45M +67,660 +10%
Norges Bank
20
Norges Bank
Norway
$41M +$1.19M +23,272 +3%
Bank of New York Mellon
21
Bank of New York Mellon
New York
$40.8M -$126K -2,482 -0.3%
ACM
22
Atlanta Capital Management
Georgia
$39.8M -$690K -13,547 -2%
Westfield Capital Management
23
Westfield Capital Management
Massachusetts
$38.8M -$1.69M -33,165 -5%
Northern Trust
24
Northern Trust
Illinois
$37.2M +$3.06M +60,122 +10%
TCM
25
Tributary Capital Management
Nebraska
$28.4M +$6.09M +119,592 +31%

IART Hedge Fund Activity: Q1 2019 in Review

259 of the 4,620 institutional investors tracked by Wall St. Rank reported a position in Integra LifeSciences (IART) for Q1 2019, worth a combined $3.96B — up 23% from $3.23B a quarter earlier.

Buyers outnumbered sellers: 47 funds opened new IART positions and 36 closed out — a net gain of 11 holders — while 100 added to existing stakes and 80 trimmed.

The largest buyer was Janus Henderson Group, adding an estimated $35.1M. The largest seller was Fidelity Investments, cutting an estimated $77.3M.

  • 259 institutional investors held Integra LifeSciences (IART) as of Q1 2019, up from 248 in Q4 2018.
  • Funds reported $3.96B of Integra LifeSciences stock for Q1 2019, up 23% quarter-over-quarter.
  • 47 funds opened new Integra LifeSciences positions in Q1 2019 and 36 closed out, a net change of +11 holders.
  • The largest Integra LifeSciences buyer in Q1 2019 was Janus Henderson Group, an estimated $35.1M added.
  • The largest Integra LifeSciences seller in Q1 2019 was Fidelity Investments, an estimated $77.3M sold.

Based on aggregated 13F filings for Q1 2019.